Vimarsana
Biggest News Aggregation in the World

Page 2 - Jaime Arango News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jaime Arango. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jaime Arango Today - Breaking & Trending Today

MedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB) - Vimarsana News

MedinCell Secures Additional 20 Million Euros Financing With the European Investment Bank (EIB)

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News:The approval obtained by the EIB is for a new credit facility of 40 million eurosThe new credit facility foresees that MedinCell (Paris:MEDCL) repays in anticipation a previous 20 million euros loan signed in 2018 with the EIB30 million euros of the credit facili...

MedinCell Receives €4 Million in Funding from Bpifrance and within the Framework of the French Recovery Plan (Plan France Relance) - Vimarsana News

MedinCell Receives €4 Million in Funding from Bpifrance and within the Framework of the French Recovery Plan (Plan France Relance)

€3 million loan for the development of a long-acting ivermectin-based drug designed to protect against Covid-19 and its variants for several weeks (mdc-TTG program) €1 million grant from the

Tremendous success for MedinCell's €30 million capital increase for qualified investors - Vimarsana News

Tremendous success for MedinCell's €30 million capital increase for qualified investors

Tremendous success for MedinCell's €30 million capital increase for qualified investors Strong support from French and international leading shareholders and investors Regulatory News: MedinCell (Paris:MEDCL) (FR0004065605 MEDCL), a clinical stage pharmaceutical company developing a portfolio of long-acting injectable products in various therapeutic areas (the " Company"), is today announcing the successful completion of its €29.8 million capital increase via a placement with French and international qualified investors through an accelerated bookbuilding process (the " Offering 1 and OD...